國立高雄大學圖資館 |

Language: English

Back

Organoids for personalised cancer medicinea vision assessment of an emerging health technology /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Organoids for personalised cancer medicineby Henrik Vogt, Maxence Gaillard, Sara Green.
Reminder of title:	a vision assessment of an emerging health technology /
Author:	Vogt, Henrik.
other author:	Gaillard, Maxence.
Published:	Cham :Springer Nature Switzerland :2025.
Description:	ix, 126 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	CancerTreatment
Online resource:	https://doi.org/10.1007/978-3-031-85535-1
ISBN:	9783031855351$q(electronic bk.)

Organoids for personalised cancer medicinea vision assessment of an emerging health technology /
Vogt, Henrik.

Organoids for personalised cancer medicinea vision assessment of an emerging health technology /[electronic resource] :by Henrik Vogt, Maxence Gaillard, Sara Green. - Cham :Springer Nature Switzerland :2025. - ix, 126 p. :ill. (some col.), digital ;24 cm. - SpringerBriefs in philosophy,2211-4556. - SpringerBriefs in philosophy..

Introduction -- Methodological development -- Vision analysis of patient-derived organoids for personalized cancer medicine -- Vision evaluation of patient-derived organoids in the clinic -- Conclusion.

Open access.

This open access book builds on and updates work performed in the HYBRIDA project, funded by the EU to develop an ethical framework for organoid research. Organoids are three-dimensional stem cell constructs that mimic organs of the body or tumours. Patient-derived organoids are envisioned to be grown from individual patients' tumours and used to tailor the most effective and safest treatments in a new form of personalized medicine. This text offers a critical assessment of this vision from the perspective of philosophy of medicine. The authors present a tailored "vision assessment", presented as examples of methodological development, and applied to objects. They first analyse and describe the vision of using organoids for personalized cancer medicine, then critically evaluate this vision and finally comment on ethical implications of the epistemological issues and how to handle them. The authors further draw on sources for empirical inquiries. This book presents an exercise in health technology assessment conducted by philosophers. Its core readership are philosophers of medicine and bioethicists interested in personalized medicine and stem cell research.

ISBN: 9783031855351$q(electronic bk.)

Standard No.: 10.1007/978-3-031-85535-1doiSubjects--Topical Terms:

809096
Cancer
--Treatment

LC Class. No.: RC270.8

Dewey Class. No.: 616.99406

Organoids for personalised cancer medicinea vision assessment of an emerging health technology /
LDR:02573nmm a2200373 a 4500 001 685512
003 DE-He213
005 20250728130253.0
006 m d
007 cr nn 008maaau
008 260129s2025 sz s 0 eng d
020 $a 9783031855351$q(electronic bk.)
020 $a 9783031855344$q(paper)
024 7 $a 10.1007/978-3-031-85535-1 $2 doi
035 $a 978-3-031-85535-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC270.8
072 7 $a HP $2 bicssc
072 7 $a MBDC $2 bicssc
072 7 $a MED050000 $2 bisacsh
072 7 $a QD $2 thema
072 7 $a MBDC $2 thema
082 0 4 $a 616.99406 $2 23
090 $a RC270.8 $b .V886 2025
100 1 $a Vogt, Henrik. $3 999598
245 1 0 $a Organoids for personalised cancer medicine $h [electronic resource] : $b a vision assessment of an emerging health technology / $c by Henrik Vogt, Maxence Gaillard, Sara Green.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2025.
300 $a ix, 126 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a SpringerBriefs in philosophy, $x 2211-4556
505 0 $a Introduction -- Methodological development -- Vision analysis of patient-derived organoids for personalized cancer medicine -- Vision evaluation of patient-derived organoids in the clinic -- Conclusion.
506 $a Open access.
520 $a This open access book builds on and updates work performed in the HYBRIDA project, funded by the EU to develop an ethical framework for organoid research. Organoids are three-dimensional stem cell constructs that mimic organs of the body or tumours. Patient-derived organoids are envisioned to be grown from individual patients' tumours and used to tailor the most effective and safest treatments in a new form of personalized medicine. This text offers a critical assessment of this vision from the perspective of philosophy of medicine. The authors present a tailored "vision assessment", presented as examples of methodological development, and applied to objects. They first analyse and describe the vision of using organoids for personalized cancer medicine, then critically evaluate this vision and finally comment on ethical implications of the epistemological issues and how to handle them. The authors further draw on sources for empirical inquiries. This book presents an exercise in health technology assessment conducted by philosophers. Its core readership are philosophers of medicine and bioethicists interested in personalized medicine and stem cell research.
650 0 $a Cancer $x Treatment $x Technological innovations. $3 809096
650 0 $a Stem cells $x Therapeutic use. $3 455512
650 0 $a Tissue engineering. $3 239499
650 1 4 $a Philosophy of Medicine. $3 275170
650 2 4 $a Clinical Medicine. $3 221285
650 2 4 $a Medical Ethics. $3 914880
650 2 4 $a Philosophy of Technology. $3 274756
700 1 $a Gaillard, Maxence. $3 999599
700 1 $a Green, Sara. $3 772619
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a SpringerBriefs in philosophy. $3 560618
856 4 0 $u https://doi.org/10.1007/978-3-031-85535-1
950 $a Religion and Philosophy (SpringerNature-41175)